Neutralizing Antibodies Against GDF-8 and Uses Therefor

Details for Australian Patent Application No. 2011203351 (hide)

Owner Cambridge Antibody Technology Limited Wyeth

Inventors Veldman, Geertruida M.; Davies, Monique V.; Song, Kening; Wolfman, Neil M.; Grove-Bridges, Kristie; Field, Anne; Russell, Caroline; Valge-Archer, Viia

Agent Cullens

Pub. Number AU-A-2011203351

Parent 2003274448

Filing date 7 July 2011

Wipo publication date 28 July 2011

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/70 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for E. coli

Event Publications

28 July 2011 Application Open to Public Inspection

  Published as AU-A-2011203351

28 July 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011203352-Silicon case

2011203350-Method for producing components, especially structural panels, from solid waste